A Study of Telitacicept in Lupus Nephritis

Recruiting now · Phase 2 · Has a placebo group

Conditions studied: Lupus Nephritis

In brief

The purpose of this study is to evaluate the safety and efficacy of Telitacicept in adult patients with active lupus nephritis.

Key facts

Study ID

NCT05680480

Run by

RemeGen Co., Ltd.

People needed

120

Starts

2023-04-17

Expected to finish

2026-01-01

Last updated by the study team

2024-09-23

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

Where it is running

• The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital) — Hefei, Anhui, China (enrolling)
• Peking University People's Hospital — Beijing, Beijing Municipality, China (enrolling)
• The First Hospital Affiliated to the Army Medical University — Chongqing, Chongqing Municipality, China (enrolling)
• The First Affiliated Hospital of Xiamen University — Xiamen, Fujian, China (enrolling)
• Zhongshan Hospital Affiliated to Xiamen University — Xiamen, Fujian, China (enrolling)
• Guangdong Provincial People's Hospital — Guangzhou, Guangdong, China (enrolling)
• The First Affiliated Hospital of Sun Yat-sen University — Guangzhou, Guangdong, China (enrolling)
• The Third Affiliated Hospital of Sun Yat-sen University — Guangzhou, Guangdong, China (enrolling)
• Liuzhou Workers' Hospital — Liuzhou, Guangxi, China (enrolling)
• Guizhou Provincial People's Hospital — Guiyang, Guizhou, China (enrolling)
• Affiliated Hospital of Hebei University — Baoding, Hebei, China (enrolling)
• Handan First Hospital — Handan, Hebei, China (enrolling)
• Hebei General Hospital — Shijiazhuang, Hebei, China (enrolling)
• The Third Affiliated Hospital of Hebei Medical University — Shijiazhuang, Hebei, China (enrolling)
• The First Affiliated Hospital of Zhengzhou University — Zhengzhou, Henan, China (enrolling)
• Xiangya Hospital of Central South University — Changsha, Hunan, China (enrolling)
• The Third Xiangya Hospital of Central South University — Changsha, Hunan, China (enrolling)
• The First Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology — Baotou, Inner Mongolia, China (enrolling)
• Zhongda Hospital Southeast University — Nanjing, Jiangsu, China (enrolling)
• Wuxi People's Hospital — Wuxi, Jiangsu, China (enrolling)
• Jiangxi Provincial People's Hospital — Nanchang, Jiangxi, China (enrolling)
• The First Hospital of Jilin University — Changchun, Jilin, China (enrolling)
• The Second Hospital of Jilin University — Changchun, Jilin, China (enrolling)
• Shengjing Hospital of China Medical University — Shenyang, Liaoning, China (enrolling)
• General Hospital of Northern Theater Command of the Chinese People's Liberation Army — Shenyang, Liaoning, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.